ASTRIA THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Description as filed by funds: The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 2028 annual meeting of stockholders: Fred Callori

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Fred Callori”): 43,513,443 for, 6,641,839 withheld, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 42 asset managers below reported 11,304,983 for, 686,975 withheld.

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

Description as filed by funds: The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 2028 annual meeting of stockholders: Jill C. Milne

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jill C. Milne”): 49,955,122 for, 200,160 withheld, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 42 asset managers below reported 11,985,844 for, 6,114 withheld.

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

Description as filed by funds: The election of three Class I Directors to our Board of Directors, to serve for a three-year term until the 2028 annual meeting of stockholders: Michael Kishbauch

ASTRIA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael Kishbauch”): 42,381,788 for, 7,773,494 withheld, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 42 asset managers below reported 11,228,059 for, 763,899 withheld.

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

Description as filed by funds: THE APPROVAL OF THE FIRST AMENDMENT TO OUR SECOND AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN, TO INCREASE THE NUMBER OF SHARES OF OUR COMMON STOCK AVAILABLE FOR GRANT UNDER THE PLAN BY 5,500,000 SHARES.

ASTRIA THERAPEUTICS INC.’s own tally for this item (“2. The first amendment to the Second Amended and Restated 2015 Plan to increase the number of shares of common stock available for grant under the plan by five million, five hundred thousan”): 42,460,419 for, 7,684,293 against — passed, per its Form 8-K filed June 12, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders of the Company approved the first amendment to the Second Amended and Restated 2015 Plan to increase the number of shares of common stock available for grant under the plan by five million, five hundred thousan”
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 42 asset managers below reported 11,154,070 for, 837,888 against.

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

Description as filed by funds: THE APPROVAL, BY NON-BINDING ADVISORY VOTE, OF OUR EXECUTIVE COMPENSATION.

ASTRIA THERAPEUTICS INC.’s own tally for this item (“4. The compensation of the Company's named executive officers”): 43,538,692 for, 6,611,451 against — passed, per its Form 8-K filed June 12, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders of the Company approved, on an advisory basis, the compensation of the Company's named executive officers.”
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of ASTRIA THERAPEUTICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (4 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 41 managers: 11,294,014 for, 683,635 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 104 managers: 38,545,977 for, 5,441,548 against, 123 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

ASTRIA THERAPEUTICS INC.’s own tally for this item (“3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 53,498,117 for, 53,293 against — passed, per its Form 8-K filed June 12, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 42 asset managers below reported 11,991,958 for.

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.